Jubilant Pharmova (BOM:530019) Total Liabilities : ₹61,274 Mil (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Total Liabilities?

Jubilant Pharmova's Total Liabilities for the quarter that ended in Mar. 2024 was ₹61,274 Mil.

Jubilant Pharmova's quarterly Total Liabilities declined from Sep. 2023 (₹59,982.00 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹61,274.00 Mil).

Jubilant Pharmova's annual Total Liabilities increased from Mar. 2022 (₹46,744.67 Mil) to Mar. 2023 (₹57,648.60 Mil) and increased from Mar. 2023 (₹57,648.60 Mil) to Mar. 2024 (₹61,274.00 Mil).

Jubilant Pharmova Total Liabilities Historical Data

The historical data trend for Jubilant Pharmova's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Total Liabilities Chart

Jubilant Pharmova Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

69,177.70

41,765.93

46,744.67

57,648.60

61,274.00

Jubilant Pharmova Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															57,648.60	-	59,982.00	-	61,274.00

Jubilant Pharmova Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Jubilant Pharmova's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18890	+	(33649	+	8735
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	61,274

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	115485	-	54211
	=	61,274

Jubilant Pharmova's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	18890	+	(33649	+	8735
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	61,274

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	115485	-	54211
	=	61,274

Jubilant Pharmova Total Liabilities Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jubilant Pharmova (BOM:530019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Total Liabilities

Traded in Other Exchanges

JUBLPHARMA:India

Address

1A, Sector 16A, Noida, UP, IND, 201 301

Website

https://www.jubilantpharmova.com

Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines